Form 10-K Kite Pharma, Inc. For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Kite Pharma (KITE) Posts Q4 Loss of 85c/Share
February 29, 2016 3:38 PM ESTKite Pharma (NASDAQ: KITE) reported Q4 EPS of ($0.85), which may not compare with the analyst estimate of ($0.71). Revenue for the quarter came in at $4.89 million versus the consensus estimate of $4.54 million.
For earnings history and earnings-related data on Kite Pharma (KITE) click here.
... More


